Hemofiltration and the middle molecule.
Henderson
L W
LW
D000686:Amyloidosis / Q000209:etiology / Q000517:prevention & control; D000855:Anorexia / Q000209:etiology / Q000517:prevention & control; D002482:Cellulose / Q000009:adverse effects / Q000031:analogs & derivatives; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000209:etiology / Q000517:prevention & control; D016207:Cytokines / Q000097:blood*; D004058:Diffusion; D006440:Hemofiltration / Q000009:adverse effects / Q000295:instrumentation; D006801:Humans; D008567:Membranes, Artificial; D008970:Molecular Weight; D009748:Nutrition Disorders / Q000209:etiology / Q000517:prevention & control; D011108:Polymers / Q000009:adverse effects; D006435:Renal Dialysis / Q000009:adverse effects / Q000295:instrumentation; D012189:Retrospective Studies; D013450:Sulfones / Q000009:adverse effects; D014511:Uremia / Q000097:blood / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D001613:beta 2-Microglobulin / Q000378:metabolism*
D016207:Cytokines; D008567:Membranes, Artificial; D011108:Polymers; D013450:Sulfones; D001613:beta 2-Microglobulin; C017662:polysulfone P 1700; D002482:Cellulose; C024671:cellulose triacetate; C009865:cuprammonium cellulose